About Maxion Therapeutics
Maxion Therapeutics helps in learning transformative therapies. It uses this technology to deliver long-acting, safe, and effective medications against previously inaccessible targets.
Company details
Funding
Total raised
$88M
Last stage
Series A
Investors
Founders
Dr. John McCafferty
Co-founded Maxion Therapeutics in 2020. Previously co-founded Cambridge Antibody Technology (acquired by AstraZeneca) and IONTAS (acquired by FairJourney Biologics). Co-invented antibody phage display, the subject of the 2018 Nobel Prize in Chemistry.
LinkedIn
Dr. Aneesh Karatt-Vellatt
Co-invented the KnotBody® technology. Previously co-founder of IONTAS Ltd. Holds a PhD in Biochemistry from the University of Cambridge. Over 10 years of experience in antibody and protein drug discovery at AstraZeneca, University of Cambridge, and IONTAS.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.